For the Inventor, By the Inventor

Enter assignee name

Greenfield, IN, United States of America

Elanco US Inc.

USPTO Granted Patents = 42

CIPO Patents = 9

EPO Patents = 20

Trademarks = 127

Forward Citations = 9

Loading Chart...

Loading Chart...

76 inventors (with patents filed for the assignee):

Peter Connor Canning (6 out of 10 patents)

Shyr Jiann Li (5 out of 12 patents)

Lam Nguyen (5 out of 12 patents)

4. Hangjun Zhan (5 out of 12 patents)

5. Ran Song (4 out of 5 patents)

6. Stephen Wu (4 out of 4 patents)

7. Kim Gene Friesen (4 out of 35 patents)

8. James David Pancook (3 out of 10 patents)

9. Nickolas Knudsen (3 out of 5 patents)

10. Nick Knudsen (3 out of 37 patents)

11. Jingdan Hu (3 out of 6 patents)

12. Catherine Bourguinat (2 out of 3 patents)

13. Timothy G Geary (2 out of 4 patents)

14. Cory T Herr (2 out of 2 patents)

15. John Charles Kube (2 out of 2 patents)

Core Competencies:

Anti-IL31 Antibodies

IL4/IL13 Receptor Molecule

Parvovirus Antibodies

G-CSF Variants

Isoxazoline Compounds

Bovine Granulocyte Colony Stimulating Factor

Porcine Reproductive and Respiratory Syndrome Vaccine

Chimeric Canine Antibodies

Feed Additive Compositions

Bovine Respiratory Disease Vaccine

Environmental Impact Reduction

Transdermal Formulations

42 patents: Sort by Forward Citations

1. 12448438 - Anti-IL31 antibodies for veterinary use (2025-10-21),

2. 12435132 - Anti-IL31 antibodies for veterinary use (2025-10-07),

3. 12428466 - IL4/IL13 receptor molecule for veterinary use (2025-09-30),

4. 12398198 - Parvovirus antibodies for veterinary use (2025-08-26),

5. 12391991 - Markers to predict macrocyclic lactone drug resistance in, the causative agent of heartworm disease (2025-08-19),

6. 12304903 - Process for making an isoxazoline compound and intermediate thereof (2025-05-20),

7. 12286462 - Porcine G-CSF variants and their uses (2025-04-29),

8. 12234239 - Crystalline forms of 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile (2025-02-25),

9. 12214032 - Porcine Reproductive and Respiratory Syndrome vaccine virus (2025-02-04),

10. 12195548 - Chimeric canine anti-CD20 antibody (2025-01-14),

11. 12161667 - Therapeutic clay compositions and methods of using (2024-12-10),

12. 12138296 - Formulations for bovine granulocyte colony stimulating factor and variants thereof (2024-11-12),

13. 12121043 - Feed additive compositions (2024-10-22),

14. 11970526 - IL4/IL13 receptor molecule for veterinary use (2024-04-30),

15. 11864567 - Methods and formulations for reducing bovine emissions (2024-01-09),

Elanco US Inc. is a leading animal health company, dedicated to providing effective solutions to improve the health and well-being of animals. With a diverse portfolio of innovative products and a strong commitment to research and development, Elanco is focused on delivering high-quality solutions for veterinarians, farmers, and pet owners. Through collaboration and strategic partnerships, the company aims to enhance global food security and promote responsible animal care.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

42 Patents

#1 in Greenfield, IN

#131 in Indiana

#7,983 in US

#15,863 in the World

Greenfield, IN, United States of America

Elanco US Inc.

Forward Citations = 9

76 inventors:

Peter Connor Canning (6 out of 10 patents)

Shyr Jiann Li (5 out of 12 patents)

Lam Nguyen (5 out of 12 patents)

4. Hangjun Zhan (5 out of 12 patents)

5. Ran Song (4 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…